Rapid and robust quantitative cartilage assessment for the clinical setting: deep learning-enhanced accelerated T2 mapping.
Authors
Affiliations (9)
Affiliations (9)
- GE HealthCare, Madrid, Spain. [email protected].
- Medical Image Analysis and Biometry Lab, Rey Juan Carlos University, Madrid, Spain. [email protected].
- GE HealthCare, Munich, Germany.
- GE HealthCare, New York, NY, USA.
- GE HealthCare, San Ramon, CA, USA.
- Department of Radiology and Biomedical Imaging, San Francisco (UCSF), University of California, San Francisco, CA, USA.
- Radiology, Stanford University, Stanford, CA, USA.
- Department of Radiology, Clínica CEMTRO, Madrid, Spain.
- Medical Image Analysis and Biometry Lab, Rey Juan Carlos University, Madrid, Spain.
Abstract
Clinical adoption of T2 mapping is limited by poor reproducibility, lengthy examination times, and cumbersome image analysis. This study aimed to develop an accelerated deep learning (DL)-enhanced cartilage T2 mapping sequence (DL CartiGram), demonstrate its repeatability and reproducibility, and evaluate its accuracy compared to conventional T2 mapping using a semi-automatic pipeline. DL CartiGram was implemented using a modified 2D Multi-Echo Spin-Echo sequence at 3 T, incorporating parallel imaging and DL-based image reconstruction. Phantom tests were performed at two sites to obtain test-retest T2 maps, using single-echo spin-echo (SE) measurements as reference values. At one site, DL CartiGram and conventional T2 mapping were performed on 43 patients. T2 values were extracted from 52 patellar and femoral compartments using DL knee segmentation and the DOSMA framework. Repeatability and reproducibility were assessed using coefficients of variation (CV), Bland-Altman analysis, and concordance correlation coefficients (CCC). T2 differences were evaluated with Wilcoxon signed-rank tests, paired t tests, and accuracy CV. Phantom tests showed intra-site repeatability with CVs ≤ 2.52% and T2 precision ≤ 1 ms. Inter-site reproducibility showed a CV of 2.74% and a CCC of 99% (CI 92-100%). Bland-Altman analysis showed a bias of 1.56 ms between sites (p = 0.03), likely due to temperature effects. In vivo, DL CartiGram reduced scan time by 40%, yielding accurate cartilage T2 measurements (CV = 0.97%) with no significant differences compared to conventional T2 mapping (p = 0.1). DL CartiGram significantly accelerates T2 mapping, while still assuring excellent repeatability and reproducibility. Combined with the semi-automatic post-processing pipeline, it emerges as a promising tool for quantitative T2 cartilage biomarker assessment in clinical settings.